← Insider buys
OCUL

Ocular Therapeutix, Inc. · Healthcare

Opaleye Management Inc. bought $59K of Ocular Therapeutix, Inc.

10% owner

Bought$58,508
$3.90Price
15,000Shares

What OCUL did for a copier

Prices for OCUL after this filing aren't in yet.

Opaleye Management Inc.'s record

63 other buys with 3 months of prices since 2016: on average +20.3% against the S&P 500, and 33 of 63 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Thu, Jan 2. Filed Fri, Jan 3, 7:45 PM ET, after the close. Not investment advice.